Global Anastomosis Devices Market Drivers:
Rise in burden of cardiac disease to propel market growth
One of the key factors expected to augment the growth of the global anastomosis devices market over the forecast period is the increasing prevalence of cardiovascular diseases worldwide. Such a high burden of cardiovascular diseases leads to an increased number of surgical procedures and is expected to increase demand for anastomosis devices. According to the WHO, cardiovascular diseases (CVDs) are the leading cause of death across the globe, taking an estimated 17.9 million lives each year. More than 4 out of 5 CVD deaths are due to heart attacks and strokes, and one third of these deaths occur in people under 70 years of age.
Global Anastomosis Devices Market Restraints:
High cost of anastomosis devices to hinder market growth
One of the key factors expected to hamper the growth of the global anastomosis devices market is the high cost of anastomosis devices. For instance, developing anastomosis devices is an extremely cost-incentive process. Moreover, developing novel devices that effectively meet the market needs requires significant investment in research and development (R&D). The high cost of anastomosis devices further increases the cost of the surgical procedure. This in turn is expected to hamper the use or adoption of anastomosis devices, restraining the market growth.
Availability of other substitutes to hamper market growth
Another factor hampering the growth of the global anastomosis devices market is the availability of other substitutes. For instance, internal substitutes, such as sutures and staplers, are increasingly being used for an anastomosis during various surgical procedures. As a result, surgeons still prefer to use sutures and staplers to perform anastomosis. Moreover, anastomosis devices found limited applications in developing countries due to the lack of marketing approval. Hence, adoption of anastomosis devices is expected to be hampered by these substitutes.
Global Anastomosis Devices Market Opportunities:
Increasing demand for anastomosis devices across the globe is expected to offer significant growth opportunities for players in the anastomosis devices market. For instance, anastomosis devices are used during a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections. In January 2023, Lydus Medical announced that the Vesseal has received FDA (Food and Drug Administration) clearance 510(k). Vesseal is a microvascular anastomosis suture deployment system, for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients